Novartis Sues Alvogen To Block Generic Dementia Patch
Novartis AG slapped generic-drug maker Alvogen Group Inc. with a lawsuit in Delaware on Friday, accusing Alvogen of infringing two patents by seeking U.S. regulatory approval to make and sell generic...To view the full article, register now.
Already a subscriber? Click here to view full article